Investments
14Portfolio Exits
5Funds
3About Consonance Capital
Consonance Capital is a healthcare investment firm that invests broadly across the healthcare landscape. Private investments, which include growth equity, leveraged buyouts, and recapitalizations, are made under the direction of Consonance Capital Partners, a private equity manager led by Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle. Public investments are made under the direction of Consonance Capital Management, a long/short public equity manager. Consonance Capital was established in 2005 and is located in New York City.
Want to inform investors similar to Consonance Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Consonance Capital News
Jul 28, 2022
11h agoPrivate EquitypehubViews: 6 Prior to joining the firm, Kim led cross-functional teams at Optum while Parepally was previously an associate at Consonance Capital. Not a member yet? Free Membership for Qualified Investors and Industry Participants Easily Customize Content to Match Your Investment Preferences Breaking News 24/7/365 Alternative Investment Listings & LeaderBoards Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets,Presentations, Investment Mandates, Video PitchBooks & More! Company Directory AUM Accelerator Program (designed for investment managers) Over 450K+ Industry Headlines, Posts and Updates ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN
Consonance Capital Investments
14 Investments
Consonance Capital has made 14 investments. Their latest investment was in Calviri as part of their Unattributed - III on November 11, 2021.
Consonance Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/9/2021 | Unattributed - III | Calviri | $5.15M | Yes | Consonance Capital, and Hauser | 1 |
8/26/2021 | Seed VC | Sugar | $2.5M | Yes | 12 | |
5/5/2021 | Seed VC | Lami | $1.8M | Yes | 16 | |
3/30/2021 | Seed VC - II | |||||
5/26/2020 | PIPE |
Date | 11/9/2021 | 8/26/2021 | 5/5/2021 | 3/30/2021 | 5/26/2020 |
|---|---|---|---|---|---|
Round | Unattributed - III | Seed VC | Seed VC | Seed VC - II | PIPE |
Company | Calviri | Sugar | Lami | ||
Amount | $5.15M | $2.5M | $1.8M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | Consonance Capital, and Hauser | ||||
Sources | 1 | 12 | 16 |
Consonance Capital Portfolio Exits
5 Portfolio Exits
Consonance Capital has 5 portfolio exits. Their latest portfolio exit was Kepro on November 09, 2022.
Consonance Capital Acquisitions
5 Acquisitions
Consonance Capital acquired 5 companies. Their latest acquisition was APS Healthcare on May 07, 2015.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
5/7/2015 | Series C | $14.15M | Acq - Fin - II | 1 | ||
8/18/2014 | ||||||
8/18/2014 | ||||||
5/29/2014 | ||||||
3/18/2014 | Private Equity |
Date | 5/7/2015 | 8/18/2014 | 8/18/2014 | 5/29/2014 | 3/18/2014 |
|---|---|---|---|---|---|
Investment Stage | Series C | Private Equity | |||
Companies | |||||
Valuation | |||||
Total Funding | $14.15M | ||||
Note | Acq - Fin - II | ||||
Sources | 1 |
Consonance Capital Fund History
3 Fund Histories
Consonance Capital has 3 funds, including Consonance Private Equity II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
4/28/2020 | Consonance Private Equity II | Industry Focused | Open | $856M | 3 |
4/24/2020 | Consonance Private Equity PV II | ||||
7/21/2014 | Consonance Capital Healthcare Fund |
Closing Date | 4/28/2020 | 4/24/2020 | 7/21/2014 |
|---|---|---|---|
Fund | Consonance Private Equity II | Consonance Private Equity PV II | Consonance Capital Healthcare Fund |
Fund Type | Industry Focused | ||
Status | Open | ||
Amount | $856M | ||
Sources | 3 |
Consonance Capital Team
3 Team Members
Consonance Capital has 3 team members, including current Founder, Chief Executive Officer, Mitchell Blutt.
Name | Work History | Title | Status |
|---|---|---|---|
Mitchell Blutt | Founder, Chief Executive Officer | Current | |
Name | Mitchell Blutt | ||
|---|---|---|---|
Work History | |||
Title | Founder, Chief Executive Officer | ||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.